GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AVITA Medical Inc (FRA:51KA) » Definitions » Cyclically Adjusted PS Ratio

AVITA Medical (FRA:51KA) Cyclically Adjusted PS Ratio : 6.02 (As of Jun. 05, 2024)


View and export this data going back to 2020. Start your Free Trial

What is AVITA Medical Cyclically Adjusted PS Ratio?

As of today (2024-06-05), AVITA Medical's current share price is €8.25. AVITA Medical's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was €1.37. AVITA Medical's Cyclically Adjusted PS Ratio for today is 6.02.

The historical rank and industry rank for AVITA Medical's Cyclically Adjusted PS Ratio or its related term are showing as below:

FRA:51KA' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 3.84   Med: 12.86   Max: 79.78
Current: 6.35

During the past years, AVITA Medical's highest Cyclically Adjusted PS Ratio was 79.78. The lowest was 3.84. And the median was 12.86.

FRA:51KA's Cyclically Adjusted PS Ratio is ranked worse than
76.73% of 477 companies
in the Medical Devices & Instruments industry
Industry Median: 2.15 vs FRA:51KA: 6.35

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

AVITA Medical's adjusted revenue per share data for the three months ended in Mar. 2024 was €0.398. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is €1.37 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


AVITA Medical Cyclically Adjusted PS Ratio Historical Data

The historical data trend for AVITA Medical's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AVITA Medical Cyclically Adjusted PS Ratio Chart

AVITA Medical Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 43.44 20.08 5.47 9.73

AVITA Medical Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.12 13.01 10.69 9.73 11.04

Competitive Comparison of AVITA Medical's Cyclically Adjusted PS Ratio

For the Medical Devices subindustry, AVITA Medical's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AVITA Medical's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AVITA Medical's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where AVITA Medical's Cyclically Adjusted PS Ratio falls into.



AVITA Medical Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

AVITA Medical's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=8.25/1.37
=6.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AVITA Medical's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, AVITA Medical's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.398/131.7762*131.7762
=0.398

Current CPI (Mar. 2024) = 131.7762.

AVITA Medical Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.000 100.560 0.000
201409 0.000 100.428 0.000
201412 0.000 99.070 0.000
201503 0.000 99.621 0.000
201506 0.000 100.684 0.000
201509 0.000 100.392 0.000
201512 0.000 99.792 0.000
201603 0.000 100.470 0.000
201606 0.000 101.688 0.000
201609 0.000 101.861 0.000
201612 0.000 101.863 0.000
201703 0.000 102.862 0.000
201706 0.000 103.349 0.000
201709 0.000 104.136 0.000
201712 0.000 104.011 0.000
201803 0.000 105.290 0.000
201806 0.000 106.317 0.000
201809 0.000 106.507 0.000
201812 0.000 105.998 0.000
201903 0.000 107.251 0.000
201906 0.000 108.070 0.000
201909 0.158 108.329 0.192
201912 0.148 108.420 0.180
202003 0.165 108.902 0.200
202006 0.161 108.767 0.195
202009 0.200 109.815 0.240
202012 0.194 109.897 0.233
202103 0.324 111.754 0.382
202106 0.344 114.631 0.395
202109 0.240 115.734 0.273
202112 0.246 117.630 0.276
202203 0.274 121.301 0.298
202206 0.316 125.017 0.333
202209 0.367 125.227 0.386
202212 0.356 125.222 0.375
202303 0.391 127.348 0.405
202306 0.430 128.729 0.440
202309 0.503 129.860 0.510
202312 0.511 129.419 0.520
202403 0.398 131.776 0.398

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


AVITA Medical  (FRA:51KA) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


AVITA Medical Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of AVITA Medical's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


AVITA Medical (FRA:51KA) Business Description

Traded in Other Exchanges
Address
28159 Avenue Stanford, Suite 220, Valencia, Los Angeles, CA, USA, 91355
Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult patients in the U.S. with paediatric clinical trials and expanded indications in soft-tissue reconstruction and vitiligo underway. It is currently in roll-out across the approximately 136 U.S. burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the U.S. region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the U.S.

AVITA Medical (FRA:51KA) Headlines

No Headlines